CCR7 chemokine receptor stimulation induces rapid but transient dendritic cell (DC) migration toward draining lymph nodes, which is critical for the initiation of protective immunity and maintenance of immune homeostasis. The mechanisms for terminating CCR7-mediated DC migration remain incompletely understood. Here we have identified a long non-coding RNA lnc-Dpf3 whose feedback restrained CCR7-mediated DC migration. CCR7 stimulation upregulated lnc-Dpf3 via removing N6-methyladenosine (m6A) modification to prevent RNA degradation. DC-specific lnc-Dpf3 deficiency increased CCR7-mediated DC migration, leading to exaggerated adaptive immune responses and inflammatory injuries. Mechanistically, CCR7 stimulation activated the HIF-1α transcription factor pathway in DCs, leading to metabolic reprogramming toward glycolysis for DC migration. lnc-Dpf3 directly bound to HIF-1α and suppressed HIF-1α-dependent transcription of the glycolytic gene Ldha, thus inhibiting DC glycolytic metabolism and migratory capacity. We demonstrate a critical role for CCR7-inducible lnc-Dpf3 in coupling epigenetic and metabolic pathways to feedback-control DC migration and inflammatory responses.
Pubmed ID: 30824325 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Software ultrafast memory efficient tool for aligning sequencing reads. Bowtie is short read aligner.
View all literature mentionsThis monoclonal targets CD40
View all literature mentionsThis monoclonal targets CD197
View all literature mentionsThis polyclonal targets DYKDDDK
View all literature mentionsThis monoclonal targets XCR1
View all literature mentionsThis monoclonal targets XCR1
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets Ly-6C
View all literature mentionsThis monoclonal targets IL-17A
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets CD197
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD45R/B220
View all literature mentionsThis monoclonal targets IFN-γ
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis polyclonal targets YTHDF2
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis polyclonal targets YTHDF1
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets H3K4me3
View all literature mentionsThis polyclonal targets DYKDDDDK Tag
View all literature mentionsThis monoclonal targets Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204)
View all literature mentionsThis monoclonal targets Polr2a
View all literature mentionsThis unknown targets mTOR
View all literature mentionsThis monoclonal targets NF-KappaB p65, phospho (Ser536)
View all literature mentionsThis polyclonal targets Phospho-mTOR (Ser2448)
View all literature mentionsThis monoclonal targets CCR7 antibody [Y59]
View all literature mentionsThis unknown targets
View all literature mentionsThis polyclonal targets Phospho-Akt (Ser473)
View all literature mentionsThis polyclonal targets HIF1 alpha antibody - ChIP Grade
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsMus musculus with name B6.Cg-Tg(Itgax-cre)1-1Reiz/J from IMSR.
View all literature mentionsMus musculus with name B6.129-Hif1atm3Rsjo/J from IMSR.
View all literature mentionsCell line HEK293T/17 is a Transformed cell line with a species of origin Homo sapiens (Human)
View all literature mentionsMus musculus with name B6.129-Hif1atm3Rsjo/J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Tg(Itgax-cre)1-1Reiz/J from IMSR.
View all literature mentions